WHO Board Agrees To Drop The Word ‘Counterfeit’ After 30 Years
For nearly 30 years, the United Nations World Health Organization has been referring to poor-quality and fake medicines as counterfeit. But that is about to change.
Intellectual Property Watch
Original news and analysis on international IP policy
Category Patents/Designs/Trade Secrets
Is Gates Foundation, WHO’s Biggest Private Funder, Ineligible To Join WHO?
As the World Health Organization Board prepares to consider candidate institutions to be admitted into official relations with the organisation, some health and public interest groups are raising alarm at what they see as a seeming lack of safeguard against conflicts of interest. Particular concern has been raised over admitting the Bill & Melinda Gates Foundation as an observer because of the Foundation trust’s investments in business ventures such as Coca-Cola, which they see as contrary to health goals. But the Gates Foundation, which is the biggest private donor to the WHO, said the trust is a separate entity from the foundation, and therefore does not represent any conflict of interest.
Virus Genetic Information Hot Topic At WHO; Flu Framework Under Nagoya Needs More Time
World Health Organization members decided more consideration is needed to address the genetic information of flu viruses in the organisation’s pandemic framework, and the suggestion to have the framework considered as a special instrument under the Nagoya Protocol on access and benefit sharing of genetic resources.
WHO, Netherlands To Hold Fair Drug Pricing Forum In May
The World Health Organization and The Netherlands government will co-host a meeting in the spring that brings experts together to look at high drug prices and the purchasing of medicines.
US Army Extends Comment Period On Proposed Exclusive Zika Licence
The US Army has extended the comment period on the proposed licence to pharmaceutical company Sanofi on technology necessary to create a vaccine for the Zika virus. This is the second extension, and will permit public comments through 10 March 2017.
Antimicrobial Resistance At WHO: Accelerating National Plans, Ensuring Accessibility
The rising threat of “super bugs,” bacteria resistant to existing antibiotics, was in discussion at the World Health Organization this week. Concerns were voiced about the slow pace of national action plan implementation to improve the careful use of antibiotics. Meanwhile some developing countries and civil society called for priority to be given to accessibility and affordability to new antibiotics.
WHO Fine-Tunes Work On Epidemics In Debates On IHRs, R&D Blueprint
The Ebola outbreak spurred actions from the World Health Organization in terms of how to deal with emergencies and also getting medicines and vaccines to patients in emergency situations. The secretariat presented an implementation plan for the International Health Regulations, and a report on its recent blueprint on research and development for potentially epidemic diseases at its Executive Board meeting this week. The United States sought to limit the scope of WHO's work on R&D in this context.
WHO Director General Candidates Hold Colorful Meeting With The Press
The three remaining candidates to be director general of the World Health Organization today met at length with UN journalists in the WHO and highlighted their plans for reform including finding new sources of funding for the continually cash-strapped UN agency that now could face threats from the US president to cut US funding.
WHO Director Candidates Down To Three, Europe Drops In Ranking
The number of candidates to be the next director general of the World Health Organization was reduced from five to three tonight, with Ethiopia, Pakistan and the United Kingdom still in the running. But in a race as unpredictable as this one, delegates and observers in the hallway were both surprised and not surprised by the outcome as Europe fell to the bottom of the list.
Medicines Patent Pool TB Deal Praised But Raises Concerns Of Affordability
The Medicines Patent Pool announced today that it has signed a license agreement with Johns Hopkins University for a candidate tuberculosis treatment. Although seen as a major step forward by public health groups, they said the agreement does not include guarantees that the treatment that could be brought to the market would be affordable for all.
Canada-Europe Trade Agreement: One More Vote To Clear
Just a day after US President Donald Trump withdrew the United States from the Trans-Pacific Partnership, the International Trade Committee of the European Parliament passed a recommendation in favour of adopting the Comprehensive Economic and Trade Agreement (CETA) between Canada and the EU. Meanwhile, the EU Trade Commissioner said trade is not to blame and the EU will negotiate many trade deals this year.
WHO Board Trims Candidates For Director To Five; Two More Cuts Tomorrow
World Health Organization members took the first step toward choosing the next director general of the UN health agency today as they narrowed the candidates to five. There will be interviews held with the remaining candidates tomorrow, after which the list will be reduced to three until the May World Health Assembly.